All News

Article

Will AI put me out of a job?

Adela Castro, MD Feb 11, 2025

The development of AI and other technologies brings new possibilities for optimizing diagnosis, management and has potential for improving outcomes in RA. At RheumNow Live 2025, Dr. Jeff Curtis, University of Alabama at Birmingham, presented a talk on, "AI applied to Rheumatoid Arthritis Care: Practically (Not) Perfect".

Adela Castro @AdelaCastro222 How can AI be useful for RA pts and rheumatologists? -AI models have the potential for improving diagnosis, management and outcomes in RA pts. -Can also improve efficiency and clinic workflow. -Not so perfect as it sounds (hallucinations, limited… https://t.co/YA4A990p2v https://t.co/YnHtbP83Nm

Eric Dein @ericdeinmd 🏈Kick-off of @RheumNow w Jeff Curtis #RNL2025 🏈 AI in RA? Can help with Rheum Boards Questions, though AI is not confident in answers May not be better than paper charts for triage Other roles: pt chatbot, AI scribe, research populations, generate DDx,… https://t.co/3vJ2gON6tR https://t.co/3ArtaRkhJp

TheDaoIndex @KDAO2011 Potential uses of #AI for #RA -office workflow (scribe, triage) -research (match eligible pts for trials) -help with diagnosis (and likelihood of risk) -consume guidelines for disease mgmt @RADoctor #RNL2025 https://t.co/k2nOytpKBH https://t.co/7Y2OvBv9pP

https://buff.ly/3CxU9hW

-HS ttx👇 1. Lifestyle changes: smoking cessation, obesity. 2. Management of comorbidities. 3. 🔍HS- related autoimmune disorders. 4. FDA approved biologics: -Adalimumab (PIONEER 1&2) -Secukinumab (SUNRISE, SUNSHINE) -Bimekizumab (BE HEARD 1&2) "Theres no such… https://t.co/G5Voxrm3Kt https://t.co/dLGtoFZMd1

Importance of not over-relying on lab tests. We can test for what we can test for, but this is not comprehensive. For me in clinical practice - Postive antibodies can confirm diagnosis of DM but negative cannot exclude it. @RheumNow #RNL2025 https://t.co/Kyfzne4BSD

https://x.com/RichardPAConway/status/1888340276994834478/photo/1

#HOT #topic Will #Rx of #PsO PREVENT onset of #PsA Well, maybe 🤔 Alexis R Ogdie ⁦@RheumNow⁩ #RNL2025 70% of #psoriatic #arthritis is preceded by #psoriasis Still a bit of a debate re prevention of PsA https://t.co/7bce8kcjdr

https://x.com/Janetbirdope/status/1888270031428972772/photo/1

Great graph from @AlexisOgdie on the effect of biologic treatment on PsA development in psoriasis. Obvious front-loading in those who need systemic therapy. But over time those who don't appear to develop more PsA @RheumNow @RNL2025 https://t.co/UxUZyKb0NA

https://x.com/RichardPAConway/status/1888273084479668323/photo/1

Michele Petri @RheumNow #RNL2025 1 mg of prednisone -> 3% increased risk of damage Taper quickly, withdrawal slowly Make sure background therapy is on - monitor therapy with HCQ levels, early use of additional Rx https://t.co/pjFNcg99ed

https://x.com/ericdeinmd/status/1888269093851009278/photo/1

🏈Kick-off of @RheumNow w Jeff Curtis #RNL2025 🏈 AI in RA? Can help with Rheum Boards Questions, though AI is not confident in answers May not be better than paper charts for triage Other roles: pt chatbot, AI scribe, research populations, generate DDx, consume guidelines https://t.co/X43DCmt0Ov

Some pearls from RA POD at #RNL2025 -What do rheumatologists want from AI: Right drug for right patient, improving documenting in less time and possibly include multimorbidity management? -Utilize AI as enhancer not replacement of the physician. AI must be trained well in a… https://t.co/9YNmeVx4t6

https://x.com/i/web/status/1888252711205736514

OK this is ‘HOT’ App on phone for a 👇 #thermal #camera Of hands 🙌 If #hot➡️ flare of #inflammatory #arthritis And call for a #follow up apt If not — then not a flare #AI #artificial #intelligence #rheumatoid #arthritis @RheumNow #RNL25 Jeff Curtis AI in #rheum

How can AI be useful for RA pts and rheumatologists? -AI models have the potential for improving diagnosis, management and outcomes in RA pts. -Can also improve efficiency and clinic workflow. -Not so perfect as it sounds (hallucinations, limited accuracy) #RNL2025 @RheumNow https://t.co/44LUHQ1KPf

https://x.com/AdelaCastro222/status/1888226614602850782/photo/1

AI models require good Positive Predictive Value (PPV) But: PPV decreases as prevalence decreases - In choosing a successful biologic: Harder to predict more challenging patients (multiple failures, co-morbidities, etc) - ACR50 non-response is higher J Curtis @RheumNow #RNL2025 https://t.co/SdJ0FHVuSC

https://x.com/ericdeinmd/status/1888226866923798734/photo/1

#AI can help with Value Based Care…a year in remission for RA will save a lot of money. @RADoctor @rheumnow #RNL2025 https://t.co/rUpeMrDHZf

https://x.com/KDAO2011/status/1888227168070558015/photo/1

Late onset RA (LORA) aka RA diagnosed at an older age — pts have higher inflammatory markers, presents like PMR; they also have polypharmacy, comorbidities, frailty, etc that can complicate management @UnaMakris #RNL2025 @RheumNow #GeriRheum https://t.co/zqEcyg2ejw

https://x.com/KDAO2011/status/1888228907955941861/photo/1

@UnaMakris #RNL25 @RheumNow Older patients w RA 1/3 of pts onset >60-65 - More acute onset, more systemic, more PMR-like, larger jts - Higher IL-6, lower TNF-a, less RF, higher ESR -Co-morbidities, polypharmacy, cognition, depression Age does not equal frailty, but does correlate https://t.co/5qb60WyKkP

https://x.com/ericdeinmd/status/1888229114814836834/photo/1

Are your patients aging with RA, or are they diagnosed with Late Onset RA (LORA)? -LORA pts tend to present acutely -High inflammatory markers~PMR Like -Seronegative/Decreased titers of RF/CCP @UnaMakris #RNL2025 @RheumNow https://t.co/aOCwb3lHef

https://x.com/AdelaCastro222/status/1888228973403939065/photo/1

Is Rheumatoid Arthritis Becoming Milder? A 24 year, prospective study analyzing very early rheumatoid arthritis (RA) in three consecutive eras suggests that RA has evolved since 2005, demonstrating less seropositivity, inflammation, and erosions but is characterized by more… https://t.co/y50uCU79i9 https://t.co/crKytLY4WN

Pain Management in Rheumatoid Arthritis BMC has published a full read literture review of pharmacological pain management in rheumatoid arthritis, pointing out that the best evidence for pain control comes from the use of DMARDs and treat-to-target strategies.… https://t.co/1rcTxpQxxT https://t.co/s20bg5FJqQ

Topics

All News

Will AI put me out of a job?

Do you get our email newsletter?